Table 3.
Univariate and multivariable analysis of factors associated with good knowledge regarding mosquito-borne diseases
| n | Univariate analysis | P | Multivariable analysis | P | |
|---|---|---|---|---|---|
| OR (95 Cl) | OR (95 Cl) | ||||
| Sex | Adjusted for sex, age, and hospital district | ||||
| Male | 218 | 1.10 (0.71–1.60) | |||
| Female | 273 | 1 | |||
| Age | |||||
| 18–29 | 48 | Adjusted for sex, age, and hospital district | 1 | ||
| 30–39 | 53 | 1.75 (0.64–5.09) | |||
| 40–49 | 37 | 2.79 (0.95–8.56) | |||
| 50–59 | 80 | 4.62 (1.87–12.51) | 8.782e–07 | ||
| 60–69 | 115 | 7. 68 (3.20–20.33) | |||
| 70–79 | 119 | 6.79 (2.86–17.82) | |||
| 80+ | 39 | 3.53 (1.24—10.65) | |||
| Hospital district | Adjusted for sex, age, and hospital district | ||||
| Ahvenanmaa | 27 | 0.62 (0.11–3.32) | |||
| Etelä-Karjala | 23 | 1.64 (0.45–6.15) | |||
| Etelä-Pohjanmaa | 15 | 2.45 (0.57–11.30) | |||
| Etelä-Savo | 19 | 1.27 (0.34–4.88) | |||
| HUS | 22 | 1 | |||
| Itä-Savo | 27 | 2.31 (0.64–8.90) | |||
| Kainuu | 22 | 1.17 (0.32–4.36) | |||
| Kanta-Häme | 33 | 0.92 (0.28–3.07) | |||
| Keski-Pohjanmaa | 26 | 1.46 (0.40–5.41) | |||
| Keski-Suomi | 27 | 1.03 (0.29–3.72) | |||
| Kymenlaakso | 23 | 0.68 (0.18–2.49) | 0.61 | ||
| Lappi | 22 | 0.52 (0.12–2.14) | |||
| Länsi-Pohja | 17 | 0.86 (0.23–3.23) | |||
| Pirkanmaa | 26 | 1.18 (0.32–4.46) | |||
| Pohjois-Karjala | 22 | 1.12 (0.30–4.20) | |||
| Pohjois-Pohjanmaa | 18 | 0.72 (0.18–2.85) | |||
| Pohjois-Savo | 26 | 2.44 (0.70–8.88) | |||
| Päijät-Häme | 18 | 1.19 (0.30–4.80) | |||
| Satakunta | 24 | 0.57 (0.15–2.14) | |||
| Vaasa | 21 | 1.40 (0.32–6.34) | |||
| Varsinais-Suomi | 35 | 0.97 (0.29–3.31) | |||
| Highest education | Not in the model | ||||
| Comprehensive | 104 | 0.56 (0.29–1.05) | |||
| Secondary high school or vocational school | 195 | 0.67 (0.40–1.12) | 066559 | ||
| Bachelor or university of applied sciences | 118 | 1 | |||
| Masters of doctorate | 70 | 0.65 (0.33–1.27) | |||
| TBE vaccination status | Not in the model | ||||
| Not vaccinated | 379 | 1 | Ref | ||
| Vaccinated | 102 | 0.76 (0.44–1.31) | 0.33 | ||
| Personal history of VBD infection | Not in the model | ||||
| No | 433 | 1 | Ref | ||
| Yes | 46 | 1.44 (0.69–3.08) | 0.34 | ||
| History of VBD infection with family and friends | Not in the model | ||||
| No | 398 | 1 | Ref | ||
| Yes | 81 | 1.41 (0.79–2.54) | 0.25 | ||
| Language | |||||
| Finnish | 442 | 1 | Ref | 1 | |
| Swedish | 49 | 0.25 (0.08–0.71) | 0.01 | 0.27 (0.08–0.79) | 0.00006 |
| Activity | |||||
| Daily | 136 | 1.21 (0.71–2.06) | 1.25 (0.73–2.14) | ||
| 3–4 times a week | 141 | 1 | 1 | ||
| About once a week | 92 | 0.67 (0.36–1.21) | 0.68 (0.37–1.23) | ||
| A few times a month | 40 | 0.53(0.23–1.17) | 0.53 (0.23–1.19) | ||
| About once a month | 3 | 0.41 (0.02–5.59) | 0.41 (0.02–5.62) | ||
| Less frequently | 21 | 0.73 (0.25–2.02) | 0.79 (0.27–2.20) | ||
| Never | 4 | 4.44 (0.49–98.07) | 2.43 (0.36–78.2) | ||
| Acitivity varies | 51 | 0.84 (0.41–1.72) | 0.82 (0.40–1.67) | ||